Research Paper Volume 15, Issue 9 pp 3690—3714
MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma
Figure 1. Flowchart of research. (A) Pan-cancer analysis. (B) Clinical features. (C) Prognosis analysis. (D) Biological functions. (E) Immune features. (F) Genetic variations. (G) Experimental verification. (H) Treatment response of MGME1 in LGG.